Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
10/21/2009 | CN101563365A Anti-IL-6 monoclonal antibodies and uses thereof |
10/21/2009 | CN101563091A Composition comprising crustacean gastrolith components and its use |
10/21/2009 | CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
10/21/2009 | CN101559255A Compound electret membrane, preparation method thereof and use thereof |
10/21/2009 | CN101559218A Composition with function of increasing bone density |
10/21/2009 | CN101559211A Method for producing drugs for treating osteomyelitis |
10/21/2009 | CN101559208A Traditional Chinese medicine composition for curing cervical spondylosis, lumbar intervertebral disc protrusion and rheumatoid arthritis |
10/21/2009 | CN101559207A Chinese patent medicine for treating cervical spondylosis |
10/21/2009 | CN101559198A Medicament for protecting joints and soft tissues |
10/21/2009 | CN101559128A Externally used medicine for expelling wind and clearing away cold, activating meridians to stop pain and preparation method thereof |
10/21/2009 | CN101559111A Traditional Chinese medicine composition for curing rheumatism, scapulohumeral periarthritis, cervical spondylosis and lumbar vertebra disease |
10/21/2009 | CN101559098A Chinese patent medicine for treating scapulohumeral periarthritis |
10/21/2009 | CN101559094A Production technique for extracting and separating isoflavone from red clover |
10/21/2009 | CN101559093A Effective part of climbing entada, preparation method thereof and pharmaceutical composition thereof |
10/21/2009 | CN101559089A Auxiliary treating method for lumbar intervertebral disc protrusion |
10/21/2009 | CN101559079A Medicinal porcine anterior pituitary and adrenal cortex extract oral capsule |
10/21/2009 | CN101559072A Application of polycation compound in related angiogenesis diseases |
10/21/2009 | CN101559062A Quinazoline derivatives which promote the release of parathyroid hormone |
10/21/2009 | CN100552016C Bifidobacterium in treatment of inflammatory disease |
10/21/2009 | CN100551422C Oral medicine for treating protrusion of lumbar intervertebral disc |
10/21/2009 | CN100551419C Medicated liquor for treating traumatic injury and arthritis |
10/21/2009 | CN100551418C Externally applied medicine for treating traumatic injury and arthritis |
10/21/2009 | CN100551415C Externally applied medicine for treating traumatic injury and arthritis |
10/21/2009 | CN100551408C Traumatic injury-treating medicated liquor |
10/21/2009 | CN100551407C Traumatic injury-treating medicated liquor |
10/21/2009 | CN100551406C Externally applied medicine for treating injuries from falls and arthritis |
10/21/2009 | CN100551392C Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis |
10/21/2009 | CN100551390C Externally applied medicament for treating bone fracture |
10/21/2009 | CN100551389C Medicine for treating early bone tumor |
10/21/2009 | CN100551388C An injection containing phenylpropanolid glycosides, its preparation method and use |
10/21/2009 | CN100551386C Dry coating sustained-release tablet for treating arthritis and preparation process thereof |
10/21/2009 | CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation |
10/21/2009 | CN100551377C Bisphosphonic acid for the treatment and prevention of osteoporosis |
10/21/2009 | CN100551359C Red medicine thin film coating tablet |
10/20/2009 | US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
10/20/2009 | US7605160 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
10/20/2009 | US7605159 Cathepsin cysteine protease inhibitors and their use |
10/20/2009 | US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy |
10/20/2009 | US7605151 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
10/20/2009 | US7605140 Endothelial growth factors; antiischemic agents; neovascularization |
10/20/2009 | CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
10/20/2009 | CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
10/20/2009 | CA2397591C Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
10/20/2009 | CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
10/20/2009 | CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases |
10/20/2009 | CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
10/20/2009 | CA2287965C Treatment or prevention of menopausal symptoms and osteoporosis |
10/15/2009 | WO2009126923A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
10/15/2009 | WO2009126513A1 Colchicine solid complex; methods of making; and methods of use thereof |
10/15/2009 | WO2009125861A1 Cysteine protease inhibitor |
10/15/2009 | WO2009124962A2 Sulfonamides |
10/15/2009 | WO2009105214A3 Selective androgen receptor modulators |
10/15/2009 | WO2009097228A3 Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
10/15/2009 | WO2009095798A3 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis |
10/15/2009 | WO2009086123A8 Imidazo [1,2-a] pyridine compounds |
10/15/2009 | WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site |
10/15/2009 | WO2009065920A3 Compounds |
10/15/2009 | WO2009015000A8 Pyrazole urea derivatives used as kinase inhibitors |
10/15/2009 | US20090259025 Lactoferrin |
10/15/2009 | US20090258942 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
10/15/2009 | US20090258936 Cxcr2 inhibitors |
10/15/2009 | US20090258918 EP4 receptor agonist, compositions and methods thereof |
10/15/2009 | US20090258906 Cxcr2 antagonists |
10/15/2009 | US20090258902 Biphenyl-pyrazolecarboxamide compounds |
10/15/2009 | US20090258884 Substituted amides |
10/15/2009 | US20090258879 Method for treating cancer, rheumatoid arthritis and other medical diseases by utilizing modified virus virions to insert medications into targeted cells |
10/15/2009 | US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
10/15/2009 | US20090258052 Compounds and methods for altering bone growth |
10/15/2009 | US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides |
10/15/2009 | US20090258013 Novel compositions and methods for the treatment of immune related diseases |
10/15/2009 | US20090258012 Compositions and methods for treating inflammatory disorders |
10/15/2009 | US20090257989 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells |
10/15/2009 | DE102008015607A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis |
10/15/2009 | CA2721080A1 Estrogenic extracts of anemarrhena asphodeloides bge. from the liliaceae family and uses thereof |
10/15/2009 | CA2720530A1 Sulfonamides |
10/14/2009 | EP2108655A1 Immune-modulating peptide |
10/14/2009 | EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
10/14/2009 | EP1494661B1 Ptx3 gene expression suppressing method |
10/14/2009 | EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
10/14/2009 | EP1356046B1 Cytokine receptor zcytor19 |
10/14/2009 | EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors |
10/14/2009 | EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis |
10/14/2009 | CN101558078A Macrolide compounds endowed with antiinflammatory activity |
10/14/2009 | CN101558072A Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
10/14/2009 | CN101555487A RNA interference carrier used for osteoporosis and rat mesenchymal stem cells |
10/14/2009 | CN101555482A Fusion protein of human parathyrine (1-34) diad and human seralbumin and preparation thereof |
10/14/2009 | CN101554468A Traditional Chinese medicine preparation for curing rachitis |
10/14/2009 | CN101554452A External application plaster and application thereof |
10/14/2009 | CN101554448A Traditional Chinese medicine composition for treating bone diseases of cervical vertebra, lumbar vertebra, and the like and preparation method thereof |
10/14/2009 | CN101554435A Traditional chinese medicine tea |
10/14/2009 | CN101554433A Medical liquor for specially curing hyperosteogeny and preparation method and application method thereof |
10/14/2009 | CN101554427A Traditional Chinese medicine compound gel for treating osteoporosis and preparation method thereof |
10/14/2009 | CN101554402A Medicine for treating rheumatism and rheumatic diseases and preparation method thereof |
10/14/2009 | CN101554398A Externally applied medical ointment for treating surgical infection and gout and preparation method thereof |
10/14/2009 | CN101554390A Medicated wine for curing scapulohumeral periarthritis |
10/14/2009 | CN101554364A Bulleyaconitine A micro-balloons and bulleyaconitine A long-acting injection and preparation method and application of same |
10/14/2009 | CN101554231A Functional food for preventing and improving osteoporosis |
10/14/2009 | CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation |
10/14/2009 | CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine |
10/14/2009 | CN100548986C Cathepsin cysteine protease inhibitors |